But now they’ve taken on the greatest challenge of all - death itself.
TIME has played host to several articles featuring ’longevity insiders’, and how they are determined to pull this off...
--- Google vs. Death By Harry McCracken; Lev Grossman | TIME
Larry Page, 40, is the co-founder and CEO of one of the most successful, ubiquitous and increasingly strange companies on the planet. Google is, of course, in the search business, and, more important for its profitability, it is in the online-advertising business. But it’s also in the driverless-car business, the wearable-computing business, and the business of providing Internet access to remote areas via high-altitude balloons, among countless others.
Page prefers to refer to the search giant’s more out-there ventures as moon shots. At the moment Google is preparing an especially uncertain and distant shot. It is planning to launch Calico, a new company that will focus on health and aging in particular. "In some industries," says Page, who spoke exclusively with TIME about the new venture, "it takes 10 or 20 years to go from an idea to something being real. Health care is certainly one of those areas. We should shoot for the things that are really, really important, so 10 or 20 years from now we have those things done."
The unavoidable question this raises is why a company built on finding information and serving ads next to it is spending untold amounts on a project that flies in the face of the basic fact of the human condition, the existential certainty of aging and death? To which the unavoidable answer is another question: Who the hell else is going to do it?
Google’s Calico: the War on Aging Has Truly Begun By Aubrey de Grey | TIME
Google’s Calico project means that hearts and minds have been convinced that we can defeat aging
To paraphrase Churchill’s words following the Second Battle of El Alamein: Google‘s announcement about their new venture to extend human life, Calico, is not the end, nor even the beginning of the end, but it is, perhaps, the end of the beginning.
Since the dawn of civilization, humanity has been enslaved by the knowledge that no lifestyle choice, no medicine, no quirk of fate can enable anyone to live for more than a few decades without suffering progressive, inexorable decline in physical and mental function, leading inevitably to death. So soul-destroying has this knowledge been, for almost everyone, that we have constructed our entire society and world view around ways to put it out of our minds, mostly by convincing ourselves that the tragedy of aging is actually a good thing. And why not? After all, why be preoccupied about something one cannot affect?
And yet, there have always been those few who aimed high: who were not cowed by this fear, but who instead found fulfilment in dedicating their lives to the crusade to bring aging under some kind of medical control. The earliest of those efforts may seem almost laughable to us today in their naivety, but that is the nature of the initial, exploratory phase of any pioneering technological quest.
The exploratory phase never ends cleanly, but rather by a series of fits and starts: leaps of faith that a judicious combination of tried and tested elements can deliver more than the sum of its parts. Often that faith is misplaced and the design fails, but that’s still progress: what is learned from the failure goes to inspire the next design, and success is eventually achieved. And so it will be with the development of medicine to maintain youth. As with any technological goal that is high on humanity’s priorities and is consistent with the laws of physics, it’s just a matter of time.
As little as 20 years ago, when I joined the pitifully small band of academics who call themselves biogerontologists, the prospects for defeating aging were so bleak that it was widely considered unscientific even to discuss it: according to the respectable view, our only option was to continue discovering more about the nature of aging until, by some miracle in the distant future, our body of knowledge took sufficient shape to reveal a route to intervention. A string of advances in the late 1990s, mostly made by researchers not focused on aging per se, changed that: it allowed, for the first time, the formulation of a realistic divide-and-conquer strategy against mankind’s most formidable foe. Many components of this strategy were at a dauntingly early stage of development, but all could be described in sufficient detail to offer hope for foreseeable success. As so often in science, many established luminaries voiced skepticism, and some still do; but the plan progressively attracted the support of world-leading experts in all the relevant disciplines, and as it has done so, funding —albeit far too little to maximise the rate of progress —has materialized too.
Now is the right time for a commercial entity to get heavily involved. One of the key activities of SENS Research Foundation, as a non-profit, is proof-of-concept research on key components of the anti-aging arsenal that are still too early-stage to constitute an attractive business proposition for all but the most visionary investors. But we’ve always made clear that our ultimate goal is to kick-start a real anti-aging industry: not the essentially cosmetic industry that goes by that name today, but a bona fide rejuvenation biotechnology industry, providing people with truly comprehensive restoration and preservation of youthful mental and physical function however long they live. And yes, one side-effect of this advance—a side-effect that we should all celebrate —is that most people will live a great deal longer than today, and will do so in the prime of health.
Pro-Israel bias: BBC admits editorial breach in interview with Israeli defense chief 2015-05-23 7:58
The BBC has reached a â€śprovisional findingâ€ť to uphold complaints made by Palestinian activists that the broadcaster breached its editorial guidelines in a â€śsoftâ€ť interview with the Israeli defense minister.
Complaints focused on BBC journalist Sarah Montagueâ€™s alleged failure to challenge controversial claims made by Israeli Defense Minister Moshe Yaâ€™alon.
Journalist Amena Saleem, who works with the Palestine Solidarity Campaign (PSC), wrote ...
41% of Americans Support Criminalizing "Hate Speech" 2015-05-23 7:31 The following are from a recent poll about what some are calling on for "hate speech"
1. Support for Hate Crimes Legislation
Do you support or oppose the federal law that requires increased penalties for hate crimes committed on the basis of the actual or perceived race, color, religion, national origin, ethnicity, or gender of any person?
2. Support for Expanding Hate Crimes
FBI Admits No Major Cases Cracked with Patriot Act Snooping Powers 2015-05-23 7:36
FBI agents canâ€™t point to any major terrorism cases theyâ€™ve cracked thanks to the key snooping powers in the Patriot Act, the Justice Departmentâ€™s inspector general said in a report Thursday that could complicate efforts to keep key parts of the law operating.
Inspector General Michael E. Horowitz said that between 2004 and 2009, the FBI tripled its use of bulk ...
Sweetener Stevia Was Once Hailed As An Anti-Fertility Agent for Population Reduction 2015-05-23 7:13
Maybe it's not so sweet now... If you've thought stevia, the natural alternative to sugar and artificial sweetners with aspartame, et al., is too good to be true, there may be a catch. Check out this textbook written in 1970 by Paul and Anne Ehrlich, the precursor to the textbook Ecoscience they wrote with Obama Science Czar John P. Holdren ...
TPP Aproved: Senate Republicans Give Obama New Powers - Details Remain 'Classified' 2015-05-23 6:43
President Obama won a big victory for his trade agenda Friday with the Senateâ€™s approval of fast-track legislation that could make it easier for him to complete a wide-ranging trade deal that would include 11 Pacific Rim nations.
A coalition of 48 Senate Republicans and 14 Democrats voted for Trade Promotion Authority late Friday, sending the legislation to a difficult fight ...